Home › NDC Lookup › RxCUI directory › RxCUI 763308

Pantoprazole 40 MG Oral Granules [Protonix] — RxCUI 763308

RxNorm drug concept · Semantic branded drug
RxCUI 763308 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI763308
Official namePantoprazole 40 MG Oral Granules [Protonix]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asProtonix 40 MG Oral Granules; Protonix 40 MG Delayed Release Oral Granules; Protonix 40 MG (pantoprazole sodium sesquihydrate 45.1 MG) Oral Granules; Protonix 40 MG Enteric Coated Oral Granules for Oral Suspension
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)10,109 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pantoprazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers stomach acid. It is used to heal and keep healed the irritation of the esophagus caused by GERD, and to treat conditions where the stomach makes too much acid, like Zolli...
  • Tablets can be taken with or without meals. If you use the granule suspension, take it about 30 minutes before a meal. Follow your prescriber’s schedule and the directions on your...
  • The most common are headache, diarrhea, nausea, belly pain, gas, and dizziness. Call your doctor for a severe rash, diarrhea that will not clear up, muscle spasms or an irregular h...
  • Some people need it long term, but your prescriber should use the lowest dose for the shortest time that works. Long-term use has been linked to fractures, low vitamin B-12, low ma...
📖 Read our full Pantoprazole guide →

🕸️ Concept Web — How Pantoprazole 40 MG Oral Granules [Protonix] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pantoprazole 40 MG Oral Granules [Protonix] RxCUI 763308

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pantoprazole 40790
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Protonix 261624
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pantoprazole Oral Granules 763305
    • Pantoprazole Granule Product 1295163
    • Pantoprazole Oral Product 1160735
    • Pantoprazole Oral Granules [Protonix] 763307
    • Protonix Granule Product 1296856
    • Protonix Oral Product 1182455
    • Oral Granules 317690
    • Granule Product 1294708
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pantoprazole 40 MG Oral Granules SCD · 763306
  • Pantoprazole 40 MG SCDC · 330396
  • Pantoprazole Oral Granules SCDF · 763305
  • Pantoprazole Granule Product SCDG · 1295163
  • Pantoprazole Oral Product SCDG · 1160735

Brand-Name Concepts

  • Pantoprazole 40 MG [Protonix] SBDC · 542447
  • Pantoprazole Oral Granules [Protonix] SBDF · 763307
  • Protonix Granule Product SBDG · 1296856
  • Protonix Oral Product SBDG · 1182455
  • Protonix BN · 261624

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 763308 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00008-0841-81 90 TABLET, DELAYED RELEASE in 1 BOTTLE (0008-0841-81) Protonix Delayed-Release Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 2000-05-01
00008-0843-81 90 TABLET, DELAYED RELEASE in 1 BOTTLE (0008-0843-81) Protonix Delayed-Release Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 2000-05-01
00008-0844-02 30 PACKET in 1 CARTON (0008-0844-02) / 1 GRANULE, DELAYED R... Protonix Delayed-Release Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 2008-02-29
Observed labelers: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.